Genecis key facts
as of Oct 2026- Operator of a climate biotech company intended to convert waste into polymers, including polyhydroxyalkanoate bioplastics.
- Genecis is valued at approximately $40.0M as of Oct 2026 (last reported valuation).
- It has raised $20.0M; the latest was Later Stage VC in Apr 2026.
- Notable investors include Y Combinator, Creative Destruction Lab, Khosla Ventures, Liquid 2 Ventures, University of Toronto — 48 tracked in total.
- Status: Privately Held (backing).
Genecis's last reported valuation, Jul 2022. Nothing priced has surfaced since.
- ·The complete investor list: 48 names
- ·Watch Genecis: the Monday email on marks, rounds and moves
Genecis funding rounds
No funding rounds for Genecis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Genecis
48+Genecis valuation
Genecis's last reported valuation was $40 million in Jul 2022. No priced round, secondary trade or fund mark has surfaced since.
Genecis investors
48 investors are on record for Genecis, including Y Combinator, Creative Destruction Lab, Khosla Ventures and Liquid 2 Ventures. By type, the record holds 6 venture capital firms and 3 growth equity firms.
About Genecis
Operator of a climate biotech company intended to convert waste into polymers, including polyhydroxyalkanoate bioplastics. The company's products include bio-based and biodegradable plastic, single-use foodware and packaging, three-dimensional-printing filaments, and the moldable plastic needed for the printing process, enabling customers to dispose of waste in a biodegradable manner.
- Sector
- Materials and Resources
- HQ
- Toronto, Canada
- Founded
- 2017
- Employees
- 14
- Website
- genecis.co/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.